IL165522A0 - Controlled ovarian hyperstimulation - Google Patents
Controlled ovarian hyperstimulationInfo
- Publication number
- IL165522A0 IL165522A0 IL16552204A IL16552204A IL165522A0 IL 165522 A0 IL165522 A0 IL 165522A0 IL 16552204 A IL16552204 A IL 16552204A IL 16552204 A IL16552204 A IL 16552204A IL 165522 A0 IL165522 A0 IL 165522A0
- Authority
- IL
- Israel
- Prior art keywords
- ovarian hyperstimulation
- controlled ovarian
- controlled
- hyperstimulation
- ovarian
- Prior art date
Links
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02077221 | 2002-06-07 | ||
| PCT/NL2003/000370 WO2003103770A2 (en) | 2002-06-07 | 2003-06-06 | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165522A0 true IL165522A0 (en) | 2006-01-15 |
Family
ID=29724462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16552204A IL165522A0 (en) | 2002-06-07 | 2004-12-02 | Controlled ovarian hyperstimulation |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7815912B2 (sr) |
| EP (1) | EP1511537B1 (sr) |
| JP (1) | JP2005530818A (sr) |
| KR (1) | KR20050058285A (sr) |
| CN (1) | CN1684737A (sr) |
| AU (1) | AU2003274929B2 (sr) |
| BR (1) | BR0305033A (sr) |
| CA (1) | CA2488719A1 (sr) |
| EA (1) | EA009371B1 (sr) |
| ES (1) | ES2399962T3 (sr) |
| IL (1) | IL165522A0 (sr) |
| IS (1) | IS7586A (sr) |
| ME (1) | MEP39308A (sr) |
| MX (1) | MXPA04012246A (sr) |
| NO (1) | NO20045304L (sr) |
| NZ (1) | NZ536984A (sr) |
| PL (1) | PL373991A1 (sr) |
| RS (1) | RS105004A (sr) |
| UA (1) | UA81251C2 (sr) |
| WO (1) | WO2003103770A2 (sr) |
| ZA (1) | ZA200409857B (sr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE473746T1 (de) * | 2007-01-08 | 2010-07-15 | Pantarhei Bioscience Bv | Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens |
| BR112014001274A2 (pt) | 2011-07-18 | 2017-04-18 | Arts Biologics As | composto de hormônio luteinizante, e, composição farmacêutica |
| US9216037B2 (en) | 2013-06-21 | 2015-12-22 | Previvo Genetics, Llc | Uterine lavage for embryo retrieval |
| US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| US9282995B2 (en) * | 2011-12-22 | 2016-03-15 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| UA127283C2 (uk) | 2016-07-21 | 2023-07-12 | Обсева С.А. | Спосіб застосування антагоніста окситоцину для сприяння імплантації ембріона і запобігання викидню |
| US20220323410A1 (en) | 2019-09-03 | 2022-10-13 | ObsEva S.A. | Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage |
| WO2021160597A1 (en) | 2020-02-10 | 2021-08-19 | ObsEva S.A. | Biomarkers for oxytocin receptor antagonist therapy |
| WO2026018221A1 (en) | 2024-07-18 | 2026-01-22 | ReproNovo SA | Crystalline compositions for improving embryo implantation and methods of using the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0788799A3 (en) * | 1996-02-07 | 1998-10-21 | ASTA Medica Aktiengesellschaft | LHRH-Antagonists in the treatment of fertility disorders |
| CN1199642A (zh) * | 1997-05-16 | 1998-11-25 | Asta药物股份公司 | 治疗不育症的lhrh－拮抗剂 |
| ATE302018T1 (de) | 1997-06-20 | 2005-09-15 | Akzo Nobel Nv | Gonadotropin releasing hormon antagonist |
| CZ301912B6 (cs) * | 1998-04-23 | 2010-07-28 | Zentaris Ivf Gmbh | Lécivo na lécení neplodnosti nitrodeložní inseminací |
| CN1353617A (zh) * | 1999-02-24 | 2002-06-12 | 诺沃挪第克公司 | 不孕症的治疗 |
| WO2001000227A1 (en) * | 1999-06-23 | 2001-01-04 | Akzo Nobel N.V. | Gonadotropin releasing hormone antagonist |
| US20030092628A1 (en) * | 1999-06-23 | 2003-05-15 | De Greef Henrik Johan Matthieu Maria | Gonadotropin releasing hormone antagonist |
| DE60231892D1 (de) * | 2001-09-12 | 2009-05-20 | Serono Lab | Verwendung von lh für die kontrollierte ovarielle hyperstimulation |
| AU2002358346A1 (en) | 2001-12-21 | 2003-07-15 | Pantarhei Bioscience B.V. | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
-
2003
- 2003-06-06 US US10/517,028 patent/US7815912B2/en not_active Expired - Fee Related
- 2003-06-06 NZ NZ536984A patent/NZ536984A/en unknown
- 2003-06-06 EA EA200401619A patent/EA009371B1/ru not_active IP Right Cessation
- 2003-06-06 JP JP2004510888A patent/JP2005530818A/ja active Pending
- 2003-06-06 UA UAA200500168A patent/UA81251C2/uk unknown
- 2003-06-06 CN CNA038183900A patent/CN1684737A/zh active Pending
- 2003-06-06 PL PL03373991A patent/PL373991A1/xx not_active Application Discontinuation
- 2003-06-06 ES ES03741621T patent/ES2399962T3/es not_active Expired - Lifetime
- 2003-06-06 ME MEP-393/08A patent/MEP39308A/xx unknown
- 2003-06-06 AU AU2003274929A patent/AU2003274929B2/en not_active Ceased
- 2003-06-06 KR KR1020047019890A patent/KR20050058285A/ko not_active Ceased
- 2003-06-06 BR BR0305033-5A patent/BR0305033A/pt not_active IP Right Cessation
- 2003-06-06 RS YUP-1050/04A patent/RS105004A/sr unknown
- 2003-06-06 CA CA002488719A patent/CA2488719A1/en not_active Abandoned
- 2003-06-06 MX MXPA04012246A patent/MXPA04012246A/es unknown
- 2003-06-06 EP EP03741621A patent/EP1511537B1/en not_active Expired - Lifetime
- 2003-06-06 WO PCT/NL2003/000370 patent/WO2003103770A2/en not_active Ceased
-
2004
- 2004-12-02 IL IL16552204A patent/IL165522A0/xx unknown
- 2004-12-03 NO NO20045304A patent/NO20045304L/no not_active Application Discontinuation
- 2004-12-03 IS IS7586A patent/IS7586A/is unknown
- 2004-12-06 ZA ZA200409857A patent/ZA200409857B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1684737A (zh) | 2005-10-19 |
| NZ536984A (en) | 2008-01-31 |
| US7815912B2 (en) | 2010-10-19 |
| MEP39308A (en) | 2011-02-10 |
| EA200401619A1 (ru) | 2005-06-30 |
| UA81251C2 (en) | 2007-12-25 |
| BR0305033A (pt) | 2004-11-09 |
| NO20045304L (no) | 2005-02-07 |
| IS7586A (is) | 2004-12-03 |
| EP1511537A2 (en) | 2005-03-09 |
| RS105004A (sr) | 2007-02-05 |
| WO2003103770A3 (en) | 2004-04-22 |
| ZA200409857B (en) | 2006-02-22 |
| ES2399962T3 (es) | 2013-04-04 |
| PL373991A1 (en) | 2005-09-19 |
| MXPA04012246A (es) | 2005-04-08 |
| KR20050058285A (ko) | 2005-06-16 |
| CA2488719A1 (en) | 2003-12-18 |
| US20050235374A1 (en) | 2005-10-20 |
| EA009371B1 (ru) | 2007-12-28 |
| AU2003274929A1 (en) | 2003-12-22 |
| WO2003103770A2 (en) | 2003-12-18 |
| AU2003274929B2 (en) | 2008-04-10 |
| EP1511537B1 (en) | 2012-11-21 |
| JP2005530818A (ja) | 2005-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2385111B (en) | Control apparatus | |
| EP1547230A4 (en) | CONTROL MOVEMENT SYSTEM | |
| GB0424797D0 (en) | CTP-extended erythropoietin | |
| GB0201228D0 (en) | Access control | |
| IL163652A0 (en) | Substituted hydroxyethylamines | |
| GB0211257D0 (en) | Novel heterocycles | |
| DE60314378D1 (en) | Kristalline polymorphe form von irinotecan-hyrochlorid | |
| GB0221167D0 (en) | Control apparatus | |
| AU2003225846A8 (en) | Variable response bushing | |
| GB0208877D0 (en) | Behicle control | |
| IL165522A0 (en) | Controlled ovarian hyperstimulation | |
| PT1487778E (pt) | Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s) | |
| IL166740A0 (en) | Substituted heterocyclylpyrimidines | |
| GB0209989D0 (en) | Novel heterocycles | |
| GB2395074B (en) | Control circuit | |
| AU150572S (en) | Control unit | |
| GB0204681D0 (en) | Ink-key control | |
| GB0511237D0 (en) | Control unit | |
| PL377325A1 (pl) | Podstawione benzodioksepiny | |
| GB2395073B (en) | Control circuit | |
| GB0209988D0 (en) | Novel Heterocycles | |
| GB0301420D0 (en) | Control belt | |
| GB0301989D0 (en) | Control belt | |
| CA94853S (en) | Lighting control | |
| GB2396065B (en) | Lighting control |